© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Valeant Acquisition of Salix Pharmaceuticals
Posted 27th February 2015

Valeant Acquisition of Salix Pharmaceuticals

NULL

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Valeant Acquisition of Salix Pharmaceuticals
Image

Valeant Acquisition of Salix Pharmaceuticals

Valeant Pharmaceuticals International, Inc. and Salix Pharmaceuticals, Ltd. announced that they have entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Salix for $158.00 per share in cash, or a total enterprise value of approximately $14.5 billion. The transaction was approved by the Boards of Directors of both companies. 

Salix Pharmaceuticals is a widely recognized gastrointestinal market leader with a portfolio of 22 total products, including well-known prescription brands Xifaxan, Uceris, Relistor, and Apriso, as well as a strong near- term pipeline of innovative, new assets. 

“Salix’s market-leading gastrointestinal franchise is an ideal strategic fit for Valeant’s diversified portfolio of specialty products,” said J. Michael Pearson, Valeant’s chairman and chief executive officer. “The growing GI market has attractive fundamentals, and Salix has a portfolio of terrific products that are outpacing the market in terms of volume growth and a promising near-term pipeline of innovative products. With strong brand recognition among specialist GI prescribers, a highly rated specialty sales force, and a significant product and commercial presence across the undertreated and underserved gastrointestinal market, this acquisition offers a compelling opportunity for Valeant to create a strong platform for growth and business development.” 

Thomas W. D’Alonzo, Chairman of the Board and Acting Chief Executive Officer of Salix, stated, “We are pleased to have reached an agreement with Valeant, which is a logical partner and importantly, creates immediate value for our shareholders. Combining Salix’s leading market position in gastroenterology with Valeant’s scale and resources will create a stronger and more diverse business committed to providing better health solutions to health care providers and their patients. We are proud of the accomplishments of our Salix team. Together, we have built our company into the leading gastrointestinal specialty pharmaceutical company, providing solutions for patients and healthcare providers. We look forward to working with the Valeant team to ensure a smooth transition.”

To find out more information about either company, please visit www.valeant.com or www.salix.com.

Categories: M&A, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
Ten Key Benefits of Being a Realtor in Nebraska
Corporate Social Responsibility
01/03/2023Ten Key Benefits of Being a Realtor in Nebraska

Are you planning to become a real estate agent? Nebraska's real estate market is healthy, home prices are skyrocketing, and there are many options and types of real estate on the market.

Read Full PostRead - Eye Icon
Private Risk Capital Development Advisors, LLC, Leading the way in PPLA and PPA Solutions
Finance
16/06/2020Private Risk Capital Development Advisors, LLC, Leading the way in PPLA and PPA Solutions

When it comes to Private Placement Life Insurance (PPLI) and Private Placement Annuity (PPA), the firm that supports you must be one you trust implicitly. It’s a business where every detail must be tended to with care. The team at Private Risk Capital Develo

Read Full PostRead - Eye Icon
Getting a Personal Loan in 2023
Finance
10/05/2023Getting a Personal Loan in 2023

As of 2023, it’s been estimated that more than £33,000, or almost $40,000, is owed per average borrower in the United Kingdom and the USA. This debt is of course subject to interest, meaning that for the estimated amount owed, more will be required by lende

Read Full PostRead - Eye Icon
Equistone Partners acquire Averys
M&A
08/04/2015Equistone Partners acquire Averys

Equistone Partners acquire Averys

Read Full PostRead - Eye Icon
7 Different Ways AI is Being Used in Small Businesses
News
29/12/20237 Different Ways AI is Being Used in Small Businesses

In the bustling café of modern commerce, where every startup owner juggles cups of ambition and plates of responsibility, a discreetly powerful barista named AI is revolutionizing service.  This digital maestro brews up a potent blend, infusing ope

Read Full PostRead - Eye Icon
Best Mortgage Brokerage 2024 – South Carolina
Finance
27/08/2024Best Mortgage Brokerage 2024 – South Carolina

Applying for a mortgage is a highly situational process, which means that reaching the best deal depends on many personal factors, so getting there relies on the personal touch. Timeless Mortgage is the face of personalized mortgage brokerage in South Carolina

Read Full PostRead - Eye Icon
Intelligent proliferation: Using AI effectively
Strategy
26/04/2021Intelligent proliferation: Using AI effectively

Nate Burke, CEO of Diginius, a UK provider of proprietary software for digital marketing and ecommerce solutions, believes businesses could be getting more out of their use of AI. In this piece, he explains how businesses can use intelligent proliferation to t

Read Full PostRead - Eye Icon
AI and Machine Learning Skills in Highest Demand from Employers in 2024
News
26/02/2024AI and Machine Learning Skills in Highest Demand from Employers in 2024

Nearly a third of employees have little understanding of how to use AI and data and less than one in ten have received training on AI tools in the past 12 months

Read Full PostRead - Eye Icon
Boomi Unveils New Vision with Strategic Acquisitions and Latest Innovations at Boomi World 2024
Innovation
09/05/2024Boomi Unveils New Vision with Strategic Acquisitions and Latest Innovations at Boomi World 2024

Boomi™, the intelligent integration and automation leader, today unveiled its vision for the company’s future, along with strategic acquisitions and key product announcements at Boomi World 2024. With more than 20,000 global customers and a network of



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow